These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 3459138

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K, Tanaki T, Horita H, Yoshitani H, Kumatani Y, Matsuda T, Ito K.
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract] [Full Text] [Related]

  • 23. Plasminogen activator and plasminogen activator inhibitor gene expression in human saphenous vein organ culture.
    Javed Q, Swanson N, Warner EL, Gershlick AH, de Bono DP.
    Exp Mol Pathol; 2001 Apr; 70(2):146-53. PubMed ID: 11263957
    [Abstract] [Full Text] [Related]

  • 24. [In-vitro "thromboplastic" activity of leukocytes and intravascular blood coagulation in leukemias].
    Gouault-Heilmann M, Varet B, Romano C, Josso F.
    Pathol Biol (Paris); 1972 Dec; ():Suppl:56-64. PubMed ID: 4574606
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pathophysiology of disseminated intravascular coagulation syndrome.
    Sakuragawa N.
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1057-65. PubMed ID: 286489
    [No Abstract] [Full Text] [Related]

  • 29. Plasma alpha2-plasmin inhibitor levels in patients with leukemia.
    Kageyama T, Oyabu H, Dohi T, Matsumoto K, Tsumoto S.
    Bull Osaka Med Sch; 1983 Jul; 29(1):36-42. PubMed ID: 6589023
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Heparin as treatment for hypercoagulability syndrome in a case of acute promyelocytic leukemia].
    Pizzuto J, Gonzalez Llaven J, Uribe Cortes JA.
    Sangre (Barc); 1969 Jul; 14(3):363-70. PubMed ID: 5288844
    [No Abstract] [Full Text] [Related]

  • 33. [Neurologic manifestations in acute leukemia: etiology, diagnosis and treatment].
    de Vaan GA.
    Ned Tijdschr Geneeskd; 1974 Mar 09; 118(10):336-42. PubMed ID: 4521867
    [No Abstract] [Full Text] [Related]

  • 34. Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor.
    Nadir Y, Katz T, Sarig G, Hoffman R, Oliven A, Rowe JM, Brenner B.
    Haematologica; 2005 Nov 09; 90(11):1549-56. PubMed ID: 16266903
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Intravascular coagulation in promyelocytic leukemia: a case study including ultrastructure.
    Albarracin NS, Haust MD.
    Am J Clin Pathol; 1971 Jun 09; 55(6):677-85. PubMed ID: 5284531
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Intracoronary urokinase for restoring circulation in occluded saphenous vein grafts.
    Dolman S, Paradiso-Hardy F.
    Crit Care Nurse; 1996 Dec 09; 16(6):24-7, 31-7; quiz 38-9. PubMed ID: 9004598
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.